Given that it is more feasible to develop small molecule compounds targeting GPCRs, compared to transcription factors, which generally considering undruggable, elucidating the specific pathophysiological mechanisms of GPR68 regulating melanoma growth may provide exciting opportunities for novel drug development against melanoma. This evidence concerns the gene GPR68 and melanoma.